We recently examined the effects of PI polyamide targeting the AP-1 binding site of the TGF-β1 promoter on diabetic nephropathy in streptozotocin (STZ)-induced diabetes mellitus in rats, in which we did not find improvement of histological degeneration [9]. Here, TGFB1 is linked to diabetic kidney disease.